ES2170060T3 - Procedimiento para la preparacion de albumina serica humana recombinante. - Google Patents

Procedimiento para la preparacion de albumina serica humana recombinante.

Info

Publication number
ES2170060T3
ES2170060T3 ES93108099T ES93108099T ES2170060T3 ES 2170060 T3 ES2170060 T3 ES 2170060T3 ES 93108099 T ES93108099 T ES 93108099T ES 93108099 T ES93108099 T ES 93108099T ES 2170060 T3 ES2170060 T3 ES 2170060T3
Authority
ES
Spain
Prior art keywords
human serum
changer
procedure
preparation
serum albumin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93108099T
Other languages
English (en)
Inventor
Takao Ohmura
Akinori Sumi
Wataru Ohtani
Naoto Fuluhata
Kazuya Takeshima
Kaeko Kamide
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27527151&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2170060(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP4127673A external-priority patent/JPH07102148B2/ja
Priority claimed from JP4137250A external-priority patent/JPH0675513B2/ja
Priority claimed from JP4205636A external-priority patent/JPH0733398B2/ja
Priority claimed from JP4232340A external-priority patent/JPH0672891A/ja
Priority claimed from JP4253142A external-priority patent/JP2869417B2/ja
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Application granted granted Critical
Publication of ES2170060T3 publication Critical patent/ES2170060T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA ALBUMINA DEL SUERO HUMANO OBTENIDA MEDIANTE TECNICAS DE MANIPULACION GENETICA SE PUEDE PURIFICAR MEDIANTE UNA COMBINACION DE PASOS ESPECIFICOS EN QUE UN CULTIVO FLOTANTE OBTENIDO DE UN HUESPED PRODUCTOR DE LA ALBUMINA DEL SUERO HUMANO SE SOMETE A UNA ULTRAFILTRACION, A UN TRATAMIENTO DE CALOR, A UN TRATAMIENTO ACIDO Y A OTRA ULTRAFILTRACION SEGUIDO DE TRATAMIENTOS SUBSIGUIENTES CON UN CAMBIADOR DE CATIONES, UN PORTADOR DE UNA CORMATOGRAFIA HIDROFOBICO Y UN CAMBIADOR DE IONES Y DE UNA DESALACION PARA ASI OBTENER UNA FORMA PURA DE ALBUMINA DEL SUERO HUMANO QUE NO CONTENGA SUSTANCIALMENTE CONTAMINANTES PROTEINICOS NI POLISACARIDOS, QUE SE FORMULA EN UNA PREPARACION FARMACEUTICA. ESTE PROCESO HACE QUE SEA POSIBLE PURIFICAR DE MANERA EFICIENTE LA ALBUMINA DEL SUERO HUMANO RECOMBINANTE Y OBTENER UNA ALBUMINA DEL SUERO HUMANO SUSTANCIALMENTE PURA QUE CON CONTIENE SUSTANCIAS RELACIONADAS CON LOS HUESPEDES PRODUCTORES NI OTROS CONTAMINANTES Y NO TIENE SUSTANCIALMENTE COLOR.
ES93108099T 1992-05-20 1993-05-18 Procedimiento para la preparacion de albumina serica humana recombinante. Expired - Lifetime ES2170060T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP4127673A JPH07102148B2 (ja) 1992-05-20 1992-05-20 遺伝子操作により得られるヒト血清アルブミンの製造方法、およびそれにより得られるヒト血清アルブミン含有組成物
JP4137250A JPH0675513B2 (ja) 1992-05-28 1992-05-28 ヒト血清アルブミンの脱色方法
JP4205636A JPH0733398B2 (ja) 1992-07-31 1992-07-31 ヒト血清アルブミンの脱脂方法
JP4232340A JPH0672891A (ja) 1992-08-31 1992-08-31 ヒト血清アルブミン含有製剤
JP4253142A JP2869417B2 (ja) 1992-09-22 1992-09-22 遺伝子操作により得られるヒト血清アルブミン

Publications (1)

Publication Number Publication Date
ES2170060T3 true ES2170060T3 (es) 2002-08-01

Family

ID=27527151

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93108099T Expired - Lifetime ES2170060T3 (es) 1992-05-20 1993-05-18 Procedimiento para la preparacion de albumina serica humana recombinante.

Country Status (7)

Country Link
US (1) US5440018A (es)
EP (2) EP0570916B1 (es)
KR (2) KR100386762B1 (es)
CA (1) CA2096572A1 (es)
DE (1) DE69331507T2 (es)
DK (1) DK0570916T3 (es)
ES (1) ES2170060T3 (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06501033A (ja) * 1991-07-12 1994-01-27 ギスト　ブロカデス　ナムローゼ　フェンノートシャップ 血清アルブミンの精製方法
JPH07102147B2 (ja) * 1992-03-16 1995-11-08 株式会社ミドリ十字 ヒト血清アルブミンの着色抑制方法
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
JP3360315B2 (ja) * 1992-07-31 2002-12-24 三菱ウェルファーマ株式会社 ヒト血清アルブミンの高度精製方法
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
CA2116385A1 (en) * 1993-02-25 1994-08-26 Akinori Sumi Human serum albumin and process for producing the same
DE69434126T3 (de) * 1993-12-17 2009-07-09 Mitsubishi Pharma Corp. Verfahren zum Entfärben von menschlichemn Serum-Albumin
GB9404270D0 (en) * 1994-03-05 1994-04-20 Delta Biotechnology Ltd Yeast strains and modified albumins
JPH07308199A (ja) 1994-05-18 1995-11-28 Green Cross Corp:The ヒト血清アルブミンの製造方法
JP3702474B2 (ja) * 1994-06-01 2005-10-05 三菱ウェルファーマ株式会社 血清アルブミン製剤の製造方法
EP0699687B1 (en) * 1994-08-31 2004-01-28 Mitsubishi Pharma Corporation Process for purifying recombinant human serum albumin
DK0790767T3 (da) * 1994-11-09 2002-02-04 Celadon Science Llc Forbindinger til opheling af sår og fremgangsmåder til deres konservering
WO1997031947A1 (en) * 1996-02-29 1997-09-04 Delta Biotechnology Limited High purity albumin production process
US6713084B1 (en) 1997-01-17 2004-03-30 Celadon Science, Llc Methods for promoting healing of skin resurfacing wounds
US6541028B1 (en) 1997-01-17 2003-04-01 Celadon Science, Llc Methods for promoting healing of corneal resurfacing wounds
CN1119352C (zh) * 1998-05-15 2003-08-27 中国科学院上海生物化学研究所 人血清白蛋白在毕赤酵母中的表达与纯化
DE19831061A1 (de) * 1998-07-10 2000-01-13 Rotkreuzstiftung Zentrallab Herstellung von Proteinpräparationen mit verringertem Aggregatgehalt
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
JP2000288079A (ja) 1999-04-07 2000-10-17 Toyobo Co Ltd 生体組織用接着剤
JP4798833B2 (ja) 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 加熱処理工程を含むヒト血清アルブミンの製造方法
WO2002034785A1 (fr) * 2000-10-24 2002-05-02 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Procede de monomerisation de polymeres d"albumine serique humaine
JP4798832B2 (ja) * 2000-10-24 2011-10-19 一般財団法人化学及血清療法研究所 ヒト血清アルブミン多量体の除去方法
JP2002265383A (ja) * 2001-03-14 2002-09-18 Mitsubishi Pharma Corp インターフェロンα注射用液状製剤
ITBO20010426A1 (it) * 2001-07-06 2003-01-06 Alfa Wassermann Spa Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico
US7351800B2 (en) * 2002-02-28 2008-04-01 Nipro Corporation Stabilized albumin preparations
SE526227C2 (sv) * 2002-05-15 2005-08-02 North China Pharmaceutical Group Metod för rening av rekombinant humant serumalbumin
CN1756587A (zh) * 2003-03-12 2006-04-05 弗雷泽纽斯卡比德国有限公司 重组白蛋白在肝衰竭后透析中的用途
PL1678314T3 (pl) * 2003-10-22 2013-02-28 Keck Graduate Inst Sposoby syntezy polipeptydów heteromultimerycznych w drożdżach, wykorzystujące strategię kojarzenia haploidalnego
EP1710250B1 (en) 2004-01-20 2009-04-15 Juridical Foundation, The Chemo-Sero-Therapeutic Research Institute Method for preparing human serum albumin through heat-treatment in presence of divalent cation
FR2866890B1 (fr) 2004-02-27 2008-04-04 Lab Francais Du Fractionnement Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant
CN106008699A (zh) 2006-09-08 2016-10-12 Ambrx公司 经修饰的人类血浆多肽或Fc骨架和其用途
CA2724052A1 (en) * 2008-05-15 2009-11-19 R-Tech Ueno, Ltd. Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion
FR2942233B1 (fr) 2009-02-19 2015-03-13 Lfb Biotechnologies Moyens pour la purification d'une proteine du plasma sanguin, et procedes pour sa mise en oeuvre
JP6140712B2 (ja) 2011-10-11 2017-05-31 メディミューン，エルエルシー ＣＤ４０Ｌ特異的Ｔｎ３由来足場およびその使用方法
AU2013205138B2 (en) 2012-08-09 2015-06-25 Grifols, S.A. Caprylate Viral Deactivation
WO2014098464A1 (ko) * 2012-12-18 2014-06-26 이화여자대학교 산학협력단 인간혈청알부민 열안정화용 조성물 및 이를 이용한 열안정화된 인간혈청알부민의 제조방법
KR101545778B1 (ko) * 2012-12-18 2015-08-19 이화여자대학교 산학협력단 인간혈청알부민 열안정화용 조성물
KR101568360B1 (ko) 2013-08-06 2015-11-12 이화여자대학교 산학협력단 열안정화된 인간혈청알부민의 제조방법
ES2780367T3 (es) 2015-01-01 2020-08-25 Shilpa Medicare Ltd Nuevo método de purificación eficiente de albumina sérica humana
KR20240093725A (ko) * 2015-03-12 2024-06-24 메디뮨 엘엘씨 알부민 융합 단백질의 정제 방법
CN107857811A (zh) * 2017-12-20 2018-03-30 广东丹霞生物制药有限公司 一种人血白蛋白的制备工艺
CN109867720A (zh) * 2019-04-26 2019-06-11 兰州兰生血液制品有限公司 一种低铝残留量人血白蛋白的超滤方法
CN110092827A (zh) * 2019-05-16 2019-08-06 齐智 一种获得高纯度重组人血清白蛋白的纯化方法
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
US11767504B2 (en) 2020-08-14 2023-09-26 Albcura Corporation Albumin compositions and methods of producing and using same
CN112210002B (zh) * 2020-10-15 2022-06-10 楚天源创生物技术(长沙)有限公司 重组人血清白蛋白的纯化方法
EP4169938A4 (en) * 2020-12-08 2023-08-09 Tonghua Anrate Biopharmaceutical Co., Ltd RECOMBINANT PROTEIN PURIFICATION METHOD
MX2023007767A (es) 2020-12-28 2023-07-07 Davol Inc Materiales hemostaticos secos en polvo reactivos que comprenden una proteina y un agente de entrelazado a base de polietilenglicol modificado multifuncional.
CN113880908B (zh) * 2021-08-25 2024-05-14 北京伟德杰生物科技有限公司 纯化重组人血清白蛋白的融合蛋白的方法
CN113980118B (zh) * 2021-12-13 2023-06-06 广东卫伦生物制药有限公司 一种血清白蛋白脱脂方法
CN115677848A (zh) * 2022-10-24 2023-02-03 通化安睿特生物制药股份有限公司 一种制备高纯度高稳定性蛋白质的方法
CN116199768B (zh) 2023-02-27 2023-10-20 武汉禾元生物科技股份有限公司 高纯度植物源重组人血清白蛋白的制备方法及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2190437B1 (es) * 1972-07-05 1975-08-08 Merieux Inst
US4032482A (en) * 1974-03-25 1977-06-28 Miyoshi Yushi Kabushiki Kaisha Process for producing chelating resin and product produced thereby
IN150740B (es) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4391801A (en) * 1981-10-29 1983-07-05 Cutter Laboratories, Inc. Plasma protein fraction substantially free of acetate ions
SE454885B (sv) * 1984-10-19 1988-06-06 Exploaterings Ab Tbf Polymerbelagda partiklar med immobiliserade metalljoner pa sin yta jemte forfarande for framstellning derav
IL88326A (en) * 1987-11-18 1993-03-15 Gist Brocades Nv Purification of serum albumin
US4990447A (en) * 1988-06-24 1991-02-05 Gist-Brocades Nv Process for the purification of serum albumin
US5759802A (en) * 1988-10-26 1998-06-02 Tonen Corporation Production of human serum alubumin A
JP3554796B2 (ja) * 1988-10-31 2004-08-18 三菱ウェルファーマ株式会社 アルブミン製剤及びその製造方法
JPH0768137B2 (ja) * 1989-06-15 1995-07-26 株式会社ミドリ十字 アルブミン製剤及びその製法
JPH0671434B2 (ja) * 1989-09-18 1994-09-14 株式会社ミドリ十字 ヒト血清アルブミンの製造方法
US5250663A (en) * 1990-04-19 1993-10-05 Miles Inc. Preparing essentially monomeric normal human serum albumin
JP3230091B2 (ja) * 1990-06-25 2001-11-19 ウェルファイド株式会社 ヒト血清アルブミンの着色抑制方法
JPH06501033A (ja) * 1991-07-12 1994-01-27 ギスト　ブロカデス　ナムローゼ　フェンノートシャップ 血清アルブミンの精製方法

Also Published As

Publication number Publication date
DE69331507T2 (de) 2002-08-29
DE69331507D1 (de) 2002-03-14
CA2096572A1 (en) 1993-11-21
EP1099708A1 (en) 2001-05-16
KR940005800A (ko) 1994-03-22
US5440018A (en) 1995-08-08
DK0570916T3 (da) 2002-05-13
EP0570916A2 (en) 1993-11-24
KR100386762B1 (ko) 2005-12-09
EP0570916B1 (en) 2002-01-30
EP0570916A3 (en) 1994-11-23

Similar Documents

Publication Publication Date Title
ES2170060T3 (es) Procedimiento para la preparacion de albumina serica humana recombinante.
ES8501413A1 (es) Procedimiento para preparar un medicamento seguro contra hepatitis que contiene la proteina llamada inactivador cl.
DE3889275D1 (de) Sol-Gel-Verfahren zur Herstellung von dünnen lumineszierenden Filmen.
DE3888003D1 (de) Verfahren zur Herstellung keramischer Supraleiter.
ES2097801T3 (es) Procedimiento para la obtencion de resinas epoxi.
ATE9651T1 (de) Vorrichtung zur befoerderung einer oder mehrerer substanzen zwischen einem gas und einer fluessigkeit.
DE3161102D1 (en) Process for the oxidizing dehydrogenation of isobutyric acid to methacrylic acid
DE3888892D1 (de) Verfahren zur Herstellung von supraleitenden Oxiden und dünne Schichten aus diesen Oxiden.
ATE26279T1 (de) Verfahren zur isolierung und reinigung von antibiotika.
JPS57185241A (en) Separating and purifying method of amino acid
FR2277897A1 (fr) Procede de recuperation du gallium de solutions tres basiques par extraction liquide/liquide
JPS57197085A (en) System for preparing purified water
ATE47373T1 (de) Neues verfahren zur herstellung von magaldrate.
ES8703487A1 (es) Procedimiento para la preparacion de a-l-aspartil-l-fenila- lanina metil ester
DE3376332D1 (en) Process for the production of hydantoin esters
DE3674027D1 (de) Methode zur herstellung von phenylbrenztraubensaeure.
JPS523021A (en) Method for isolation of n-acylcysteine
DE69002867D1 (de) Verfahren zur Herstellung hochreiner o-Toluolsäure.
DE68921138D1 (de) Verfahren zur Herstellung eines Oxidverbindungssupraleiters des Bi-Sr-Ca-Cu-Systems.
JPS525970A (en) Independent disposing tank of long time exposing system
JPS5233654A (en) Purification process of phosphoric ester oil for electric insulating materials
DE3780665D1 (de) Mehrstufiges reduktionsverfahren zur herstellung von ferromagnetischem chromdioxid.
NO882821D0 (no) Fremgangsmaate ved fremstilling av ren oksygen for paafoelgende fremstiling av ozon.
SU1051097A1 (ru) Способ получени дихлорангидридов арилфосфоновых кислот
ATE133421T1 (de) Verfahren zur herstellung von rekombinantem humaninterferon-beta in reiner form

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 570916

Country of ref document: ES